Counterpoint: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes
- PMID: 33843282
- PMCID: PMC8238130
- DOI: 10.1152/ajpendo.00110.2021
Counterpoint: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes
Conflict of interest statement
C.S. Carter, S.C. Huang, V.C. Sheffield, C.C. Searby, and M.J. Miller have patents pending related to this work. C.S. Carter, S.C. Huang, and W.A. Carter are founders of Geminii, Inc. D.R. Spitz has a sponsored research agreement with Galera Therapeutics.
Comment in
-
Reply to Carter et al.: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes.Am J Physiol Endocrinol Metab. 2021 May 1;320(5):E1003. doi: 10.1152/ajpendo.00120.2021. Epub 2021 Apr 12. Am J Physiol Endocrinol Metab. 2021. PMID: 33843277 No abstract available.
Comment on
-
Exposure to Static Magnetic and Electric Fields Treats Type 2 Diabetes.Cell Metab. 2020 Oct 6;32(4):561-574.e7. doi: 10.1016/j.cmet.2020.09.012. Cell Metab. 2020. PMID: 33027675 Free PMC article.
-
Point: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes.Am J Physiol Endocrinol Metab. 2021 May 1;320(5):E999-E1000. doi: 10.1152/ajpendo.00657.2020. Epub 2021 Apr 12. Am J Physiol Endocrinol Metab. 2021. PMID: 33843279 No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical